tebufelone has been researched along with indomethacin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Dinarello, CA; Doyle, MJ; Schindler, R; Sirko, SP; Weisman, SM | 1 |
| Clear, RM; Coggeshall, CW; Doyle, MJ; Eichhold, TH; Hynd, BA; Kuhlenbeck, DL; Wehmeyer, KR; Weisman, SM | 1 |
3 other study(ies) available for tebufelone and indomethacin
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor.
Topics: Alkynes; Cyclooxygenase Inhibitors; Dinoprostone; Humans; In Vitro Techniques; Indomethacin; Interleukin-1; Leukotriene B4; Lipoxygenase Inhibitors; Phenols; Protein Biosynthesis; RNA, Messenger; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1991 |
Effects of tebufelone (NE-11740), a new anti-inflammatory drug, on arachidonic acid metabolism.
Topics: Alkynes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Calcimycin; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Indomethacin; Leukotriene B4; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Male; Phenols; Prostaglandin-Endoperoxide Synthases; Quinolines; Rats | 1994 |